Find a Doctor

Find a Researcher

Paul Barton Rosenberg, M.D.

Co-Director, Memory and Alzheimer's Treatment Center Division of Geriatric Psychiatry and Neuropsychiatry
Professor of Psychiatry and Behavioral Sciences

Male

Expertise

Adult Psychiatry, Alzheimer's Disease (AD), Dementia, Geriatric Psychiatry, Memory Disorders, Neuropsychiatry, Psychiatry, Psychiatry and Behavioral Sciences ...read more

Research Interests

Depression and other neuropsychiatric symptoms in Alzheimers disease; Preclinical biomarkers of Alzheimers disease, including PET and peripheral blood studies of inflammation ...read more

Request an Appointment

Insurance Information

Existing Patients

Request your next appointment through MyChart

Main Phone

410-550-6337

Outside of Maryland & Washington D.C.

410-464-6641

Request Appointment

International Patients

+1-410-502-7683

Request Appointment

Locations

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-550-6337

1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287 map

Phone: 410-550-9883

Johns Hopkins Bayview Medical Center

Appointment Phone: 410-550-6337

5501 Hopkins Bayview Circle
Asthma and Allergy Center
Baltimore, MD 21224 map

Phone: 410-550-9883

Background

Titles

Co-Director, Memory and Alzheimer's Treatment Center Division of Geriatric Psychiatry and Neuropsychiatry
Professor of Psychiatry and Behavioral Sciences

Departments / Divisions

Psychiatry and Behavioral Sciences

Centers & Institutes

Memory and Alzheimer's Disease Treatment Center

Education

Degrees

MD; University of Maryland School of Medicine (1985)

Residencies

Psychiatry; Tufts-New England Medical Center Hospitals (1990)

Fellowships

Geriatric Psychiatry; McLean Hospital (1991)

Board Certifications

American Board of Psychiatry and Neurology (Psychiatry-General) (1993)

Research & Publications

Clinical Trial Keywords

Clinical trials of new treatments for Alzheimers disease

Selected Publications

Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer’s Disease. Am J Geriatric Psychiatry 2012 (in press).

Rosenberg PB, Mielke MME, Han D, Leoutsakos JS, Lyketsos CG,Rabins PV, Zandi PP, Breitner JCS, Norton MC, Welsh-Bohmer KA, Zuckerman IH, Rattinger GB, Green RC, Corcoran D, Tschanz JT. The association of psychotropic medication use with the cognitive, functional and neuropsychiatric trajectory of Alzheimer’s disease. Int J Geriatric Psychiatry 2012 (in press)

Rosenberg PB, Wong DF, Edell S, Ross J, Joshi AD, Brašić JR, Zhou Y, Raymont V, Kumar A, Ravert HT, Dannals RF, Pontecorvo MJ, Skovronsky DM, Lyketsos CG. Cognition and amyloid load in Alzheimer’s imaged with florbetapir F 18 (AV-45) PET. American Journal of Geriatric Psychiatry 2011 (in press).

Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos J-M, Lyketsos CG. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatric Psychiatry 2010 (in press)

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos, CG, for the DIADS-2 Research Group. Sertraline for the treatment of depression in Alzheimer’s disease. American Journal of Geriatric Psychiatry 2010; 18:136-45 NIHMS166961

Activities & Honors

Honors

Paul Beeson Award Scholar, 2008

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile